Acute variceal bleeding in a patient with phaeochromocytoma: the critical choice of vasoactive therapy.

Authors

Jessica Satya Graha, Joshua Haron Abasszade, Teagan Rose Wanigaratne, Phil Ha

Published in

BMJ case reports. Volume 19. Issue 9. Sep 30, 2026. Epub Sep 30, 2026.

Abstract

A woman in her late 70s with known left-sided phaeochromocytoma presented with acute variceal bleeding secondary to suspected cirrhosis. Terlipressin, a standard first-line vasoactive agent, was contraindicated due to the risk of precipitating hypertensive crisis. Octreotide was successfully used as the preferred alternative, combined with careful alpha-blockade optimisation and endoscopic variceal ligation, achieving complete haemorrhage control without cardiovascular complications. This case highlights the need to recognise contraindications in patients with rare comorbidities and offers guidance on selecting vasoactive agents when standard treatments pose risks.

PMID:
42816107
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.